\u201cAs organisations, we have to disrupt ourselves and change ourselves because the pain if you don\u2019t is 10 times worse,\u201d says Callaghan Innovation CEO Vic Crone.\nCrone, who spoke at the first Kerridge Partners leadership series for 2017, says technology and innovation are not just providing new tools for the organisation, they are completely changing leadership paradigms.\nTechnologies will change the face of New Zealand, she says at the breakfast forum in Auckland. She says technologies that will have a big impact in businesses include drones, 3D printing, blockchain (\u2018it is a whole new way of transacting with each other\u2019) and big data.\nThe ability of sensors to collect information and have the computing capacity to analyse it will open us up to a whole new range of decisions, says Crone, who was previously managing director of Xero. She was appointed CEO at the government agency in February.\nShe says two of the individuals she looks up to are former Telecom CEO Theresa Gattung (\u201cputting herself out there...that was quite inspirational\u201d) and Xero CEO Rod Drury (\u201che doesn\u2019t care what the naysayers think\u201d).\nClayton Wakefield\nClayton Wakefield has launched TechX, which he aims to build as New Zealand\u2019s leading independent technology advisory company. \u201cOur aim is to have a team of 25 senior advisors by 2020,\u201d says Wakefield during the launch at the Seafarer\u2019s Club in Britomart, Auckland. \n "As an industry we need to help companies achieve better outcomes through and with technology in NZ. TechX is aimed as a trusted advisor to help in that improvement.\u201d\nHe says the TechX team will provide a range of services including business transformation leadership and independent guidance and mentoring at board and CX level. \nWakefield is an independent board director who has held senior executive roles at ASB and Telecom (now Spark). He was also founder of Techspace, a New Zealand technology company that was acquired by management in 2015.\nNathan Bryant-Taukiri, managing director of Potentia with Taupaki School principal Pete Hall \nRecruitment firm Potentia has provided funding for Taupaki School\u2019s \u201cFearless Future\u201d project, which aims to build pupil\u2019s digital technology and leadership skills.\nTaupaki School will receive $10,000 through the Potentia Future Innovators in Tech (FIT) programme.\n\u201cAs a key contributor to tech-focused careers of many New Zealanders, we're eager to support the next generation of innovators and ensure that this support extends all the way down to the grassroots of the technology sector,\u201d says Nathan Bryant-Taukiri, managing director of Potentia.\nPete Hall, principal of Taupaki school, says the Future Innovators in Tech grant will enable them to significantly boost their digital technology programme. \n\u201cThe best thing about the Potentia award was the freedom we were given to define the project on our own terms in a way that supported our community. We wanted this to inspire student leadership and bring our teachers and community on a journey that gets them excited and confident learning and experimenting with digital technologies, at school and at home.\u201d \nAamplify client Partner, Warwick Grey and client marketing director Simon Shaw\n\nSimon Shaw is taking up the newly created role of client marketing director at Aamplify. Shaw hails from a B2B marketing background with over 18 years\u2019 experience on both client and agency side.\nThe specialist marketing firm has grown from five staff to over 25 in four years with representation in Auckland, Sydney and Melbourne.\nSamuel Williams, Aamplify managing partner, also cites the role played by client partner Warwick Grey in growing the company. \n\u201cWarwick Grey has been instrumental in our success, both here and offshore and adding Simon to the mix will allow us to offer our clients an even greater depth of marketing expertise,\u201d says Williams.\nNo caption\nGeneious Biologics, an enterprise software solution for screening antibodies and related constructs using sequence data, has been launched and is expected to change the way scientists identify antibodies for use in biological drug development.\nThe Geneious Biologics software platform, by Kiwi company Biomatters, will allow biopharma and biotechnology enterprises to create highly annotated antibody databases, significantly improving their ability to leverage accumulated knowledge and gain insights into trends and relationships that may otherwise have been missed.\n\u201cBiopharmaceutical enterprises are generating huge volumes of data in the development of new antibody based therapeutics,\u201d says Jannick Bendtsen, Vice President of Technology Services, Geneious Biologics.\n\u201cGeneious Biologics will help them combine and analyse data from different sources and find high-value candidate antibodies much faster than they\u2019ve ever been able to before.\u201d\nNo caption\nSend news tips and comments to email@example.com\nFollow Divina Paredes on Twitter: @divinap\nFollow CIO New Zealand on Twitter:@cio_nz\nJoin us on Facebook.